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91-7902/Copyrightª 2015, AssociatioOral leukoplakia (OL) is the most common oral precan-
cerous lesion. Histologically, approximately 90% of OL
lesions show hyperkeratosis and/or epithelial hyperpla-
sia, 5% show epithelial dysplasia or carcinoma in situ, and
another 5% show invasive carcinoma. The malignant
transformation rates of OL lesions have been reported to
be 1e7% for homogenous thick leukoplakia, and 4e15%
for granular or verruciform leukoplakia.1e3 The relatively
high malignant transformation rates of OL lesions high-
light the importance of early detection and treatment of
OL lesions.
Although OL lesions can be eradicated by surgical exci-
sion, laser surgery, and photodynamic therapy, cryotherapy
is also an effective and alternative treatment modality fornt of Dentistry, National
1, Chang-Te Street, Taipei
.tw (C.-P. Chiang).
3.002
n for Dental Sciences of the RepubOL lesions.1e5 Cryotherapy is a method that locally destroys
lesional tissues by freezing in situ. It has several advantages
including being a bloodless treatment, has a very low
incidence rate of secondary infections, and has a relative
lack of scarring and pain.1e3 Cryotherapy can be carried out
with either a “closed” or an “open” system.1e3 Closed-
system cryotherapy offers a greater degree of tempera-
ture control but requires complex, delicate, and expensive
equipment. Open-system cryotherapy involves directly
applying the cryogen to the lesion with either a cotton
swab2 or a portable spray apparatus such as a cryogun
(Brymill Corp., Ellington, CT, USA).3 When performing open-
system cryotherapy, it is more difficult to maintain a con-
stant lower temperature in the lesional tissues during the
whole treatment period. However, it does not require
expensive equipment. Cotton-swab cryotherapy is suitable
for the treatment of small OL lesions,2 but cryogun cryo-
therapy can be used for the treatment of medium and large
OL lesions with either smooth or rough surfaces.3lic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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are complex, involving a combination of both direct and
indirect effects.1e3 Direct effects consist of extracellular
and intracellular formation of ice crystals which in turn
disrupt cell membranes, cellular dehydration, toxic intra-
cellular electrolyte concentration, inhibition of enzymes,
protein damage, thawing effects that cause the cell to
vacuolate, swell, and rupture, and thermal shock injury to
cells.1e3 Indirect effects include vascular changes that lead
to ischemic necrosis of the treated tissue and immunolog-
ical responses that cause cell damage through a cytotoxic
immune mechanism.1e3
Our previous study used the cotton-swab cryotherapy to
treat 60 OL lesions and found complete regression of all OL
lesions after an average of 6.3 treatments.2 For compari-
son, we used the liquid nitrogen spray with a cryogun
(cryogun cryotherapy) to treat 60 OL lesions and discovered
complete regression of all OL lesions after an average of 3.1
treatments.3 Cryogun cryotherapy seems more efficient
than cotton-swab cryotherapy for the treatment of OL le-
sions, because the former needs approximately half the
number of treatments to achieve complete regression of
nearly equal-sized OL lesions compared to the latter. In
fact, the cotton swab carries only a small amount of liquid
nitrogen that cannot maintain a constant low temperature
in the treated OL lesional tissues. On the contrary, cryogun
can deliver onto the OL lesional surface a relatively large
amount of liquid nitrogen that can maintain a more con-
stant, lower temperature in treated OL lesional tissues.
This can further explain why the cryogun cryotherapy is
more efficient in the treatment of OL lesions than the
cotton-swab cryotherapy. In addition, we also discovered
that when OL lesions are treated by either cotton-swab or
cryogun cryotherapy, those OL lesions on oral mucosal sites
other than the tongue, smaller than 2 cm,2 with epithelial
dysplasia, or with a surface keratin thickness < 55 mm
require significantly fewer cryotherapy treatments to ach-
ieve complete regression of the OL lesions than the corre-
sponding OL lesions.2,3 Recently, we used cryogun
cryotherapy to treat 72 OL and adjacent smoking-induced
melanosis (OLM) lesions. We found that complete regres-
sion was achieved in all 72 OLM lesions after a mean of
3.3  1.3 cryogun cryotherapy treatments. OLM lesions in
patients without smoking habit, with the greatest diameter
< 2.8 cm, with epithelial dysplasia, or with a surface ker-
atin thickness  50 mm needed significantly fewer cryogun
cryotherapy treatments to achieve complete regression of
the OLM lesions than the corresponding OLM lesions.4
Therefore, we suggest that cryogun cryotherapy is also an
effective treatment modality for OLM lesions.
Our previous studies found that topical 5-aminolevulinic
acid-mediated photodynamic therapy (topical ALA-PDT) is
very effective for oral erythroleukoplakia and oral verru-
cous hyperplasia lesions, but is less effective for OL le-
sions.5 However, when topical ALA-PDT is combined with
cryotherapy, the combination therapy may be an effective
treatment modality for OL lesions.5 Chang and Yu6 used
topical ALA-PDT and then cryogun cryotherapy to treat a
large oral verrucous hyperplasia lesion in the same treat-
ment and achieved complete regression of the lesion aftersix treatments of combination therapy. Actually, cryogun
cryotherapy can also be used before topical ALA-PDT in the
same treatment to facilitate the diffusion of ALA into the
precancerous epithelial cells and to improve the clinical
outcome of topical ALA-PDT.5,7 The efficacy of topical ALA-
PDT can also be enhanced by pretreatment with metho-
trexate. Pretreatment of SCC4 cells with 0.001 mg/L
methotrexate for 72 hours results in a significant increase in
methotrexate-ALA-PDT-induced killing of SCC4 cells.8 In
addition, topical methotrexate pretreatment can increase
intracellular protoporphyrin IX production in hamster
buccal pouch precancerous lesions and significantly im-
proves the outcomes of the precancerous lesions treated
with topical ALA-PDT.9 The aforementioned findings suggest
that topical ALA-PDT combined with either cryotherapy or
methotrexate pretreatment has a high potential to be used
for treatment of OL lesions.
Compared to topical ALA-PDT or combination therapy,
cryogun cryotherapy is a simple, easy, cheap, less-painful,
effective, and acceptable treatment modality for OL
lesions.1e3 Therefore, we conclude that cryogun cryo-
therapy can serve as the first-line treatment of choice for
OL lesions. Moreover, cryogun cryotherapy is also an
effective treatment modality for OLM lesions.4
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